James L. Slack

6.5k total citations · 1 hit paper
84 papers, 3.6k citations indexed

About

James L. Slack is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, James L. Slack has authored 84 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Hematology, 35 papers in Molecular Biology and 21 papers in Genetics. Recurrent topics in James L. Slack's work include Acute Myeloid Leukemia Research (42 papers), Acute Lymphoblastic Leukemia research (19 papers) and Retinoids in leukemia and cellular processes (18 papers). James L. Slack is often cited by papers focused on Acute Myeloid Leukemia Research (42 papers), Acute Lymphoblastic Leukemia research (19 papers) and Retinoids in leukemia and cellular processes (18 papers). James L. Slack collaborates with scholars based in United States, Canada and Germany. James L. Slack's co-authors include Hagop M. Kantarjian, John F. DiPersio, Maher Albitar, Paul Börnstein, C Rosenfeld, Jean‐Pierre J. Issa, Hussain I. Saba, Carlos de Castro Lozano, Azra Raza and Virginia M. Klimek and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

James L. Slack

82 papers receiving 3.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Decitabine improves patient outcomes in myelodysplastic syndromes

2006 1.1k citations Hagop M. Kantarjian, Jean‐Pierre J. Issa et al. Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
James L. Slack United States	29	2.1k	1.9k	569	548	405	84	3.6k
Paolo de Fabritiis Italy	32	1.8k 0.8×	840 0.4×	814 1.4×	570 1.0×	708 1.7×	199	3.2k
Celalettin Üstün United States	29	1.6k 0.8×	866 0.5×	498 0.9×	369 0.7×	664 1.6×	147	3.0k
Hyo Seop Ahn South Korea	27	729 0.3×	700 0.4×	573 1.0×	424 0.8×	413 1.0×	162	2.4k
Nobuko Hijiya United States	33	1.3k 0.6×	742 0.4×	617 1.1×	1.6k 2.8×	623 1.5×	116	3.3k
Francesco Lanza Italy	33	2.1k 1.0×	804 0.4×	822 1.4×	600 1.1×	1.0k 2.5×	159	3.8k
B. Kornhuber Germany	24	1.4k 0.6×	595 0.3×	375 0.7×	878 1.6×	402 1.0×	79	2.8k
Michael Rytting United States	31	2.1k 1.0×	1.1k 0.6×	656 1.2×	2.1k 3.7×	1.3k 3.3×	96	4.2k
Joseph G. Jurcic United States	32	1.3k 0.6×	1.2k 0.6×	547 1.0×	374 0.7×	1.1k 2.6×	135	4.2k
Philip C. Amrein United States	27	939 0.4×	743 0.4×	378 0.7×	452 0.8×	1.0k 2.6×	112	2.9k
Jan Starý Czechia	42	3.1k 1.5×	1.5k 0.8×	570 1.0×	2.4k 4.5×	1.0k 2.5×	255	5.0k

Countries citing papers authored by James L. Slack

Since Specialization

Citations

This map shows the geographic impact of James L. Slack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James L. Slack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James L. Slack more than expected).

Fields of papers citing papers by James L. Slack

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James L. Slack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James L. Slack. The network helps show where James L. Slack may publish in the future.

Co-authorship network of co-authors of James L. Slack

This figure shows the co-authorship network connecting the top 25 collaborators of James L. Slack. A scholar is included among the top collaborators of James L. Slack based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James L. Slack. James L. Slack is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jain, Tania, Katie L. Kunze, Luke Mountjoy, et al.. (2020). Early post-transplantation factors predict survival outcomes in patients undergoing allogeneic hematopoietic cell transplantation for myelofibrosis. Blood Cancer Journal. 10(3). 36–36. 13 indexed citations

Buras, Matthew, José F. Leis, Pierre Noël, et al.. (2019). Pretransplant body mass index on outcomes of allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplantation. 55(6). 1175–1177. 3 indexed citations

Tefferi, Ayalew, Jeanne Palmer, James L. Slack, et al.. (2018). Allogeneic hematopoietic stem cell transplant overcomes the adverse survival effect of very high risk and unfavorable karyotype in myelofibrosis. American Journal of Hematology. 93(5). 649–654. 28 indexed citations

Jain, Tania, Katie L. Kunze, M’hamed Temkit, et al.. (2018). Comparison of reduced intensity conditioning regimens used in patients undergoing hematopoietic stem cell transplantation for myelofibrosis. Bone Marrow Transplantation. 54(2). 204–211. 28 indexed citations

Ertz-Archambault, Natalie, Heidi Kosiorek, James L. Slack, et al.. (2017). Cytogenetic Evolution in Myeloid Neoplasms at Relapse after Allogeneic Hematopoietic Cell Transplantation: Association with Previous Chemotherapy and Effect on Survival. Biology of Blood and Marrow Transplantation. 23(5). 782–789. 5 indexed citations

Slack, James L., José F. Leis, Pierre Noël, et al.. (2017). Association of hematopoietic cell transplantation-specific comorbidity index with resource utilization after allogeneic transplantation. Bone Marrow Transplantation. 52(7). 998–1002. 7 indexed citations

Khera, Nandita, Yu‐Hui Chang, James L. Slack, et al.. (2014). Impact of race and ethnicity on outcomes and health care utilization after allogeneic hematopoietic cell transplantation. Leukemia & lymphoma. 56(4). 987–992. 16 indexed citations

Slack, James L., Amylou C. Dueck, Veena Fauble, et al.. (2013). Reduced Toxicity Conditioning and Allogeneic Stem Cell Transplantation in Adults Using Fludarabine, Carmustine, Melphalan, and Antithymocyte Globulin: Outcomes Depend on Disease Risk Index but Not Age, Comorbidity Score, Donor Type, or Human Leukocyte Antigen Mismatch. Biology of Blood and Marrow Transplantation. 19(8). 1167–1174. 13 indexed citations

Wijermans, P., et al.. (2007). Efficacy of decitabine in the treatment of patients with chronic myelomonocytic leukemia (CMML). Leukemia Research. 32(4). 587–591. 91 indexed citations

10.

Slack, James L. & Robert E. Gallagher. (2007). The molecular biology of acute promyelocytic leukemia. Cancer treatment and research. 99. 75–124. 8 indexed citations

11.

Gallagher, Robert E., D-C Zhou, Wei Ding, et al.. (2006). Relapse of acute promyelocytic leukemia with PML-RARα mutant subclones independent of proximate all-trans retinoic acid selection pressure. Leukemia. 20(4). 556–562. 19 indexed citations

12.

Kantarjian, Hagop M., Jean‐Pierre J. Issa, C Rosenfeld, et al.. (2006). Decitabine improves patient outcomes in myelodysplastic syndromes. Cancer. 106(8). 1794–1803. 1139 indexed citations breakdown →

13.

Hahn, Theresa, Udomsak Bunworasate, Wichai Chinratanalab, et al.. (2003). Use of nonvolume-reduced (unmanipulated after thawing) umbilical cord blood stem cells for allogeneic transplantation results in safe engraftment. Bone Marrow Transplantation. 32(2). 145–150. 18 indexed citations

14.

Hahn, Theresa, Cherie Rondeau, Aasma Shaukat, et al.. (2003). Acute renal failure requiring dialysis after allogeneic blood and marrow transplantation identifies very poor prognosis patients. Bone Marrow Transplantation. 32(4). 405–410. 57 indexed citations

15.

Slack, James L. & Michael E. Rusiniak. (2000). Current issues in the management of acute promyelocytic leukemia. Annals of Hematology. 79(5). 227–238. 33 indexed citations

16.

Schriber, J R, Darcy H. Shaw, Neal P. Christiansen, et al.. (1999). Tissue plasminogen activator (tPA) as therapy for hepatotoxicity following bone marrow transplantation. Bone Marrow Transplantation. 24(12). 1311–1314. 26 indexed citations

17.

Slack, James L.. (1999). The biology and treatment of acute progranulocytic leukemia. Current Opinion in Oncology. 11(1). 9–9. 16 indexed citations

18.

Heinonen, Kristiina, P. Nagesh Rao, James L. Slack, et al.. (1996). Isochromosome 12p in two cases of acute myeloid leukaemia without evidence of germ cell tumour. British Journal of Haematology. 93(3). 677–680. 9 indexed citations

19.

Slack, James L., M. Iqbal Parker, & Paul Börnstein. (1995). Transcriptional repression of the α1(I) collagen gene by ras is mediated in part by an intronic AP1 site. Journal of Cellular Biochemistry. 58(3). 380–392. 20 indexed citations

20.

Slack, James L., et al.. (1992). Regulation of Collagen I Gene Expression by ras. Molecular and Cellular Biology. 12(10). 4714–4723. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact